Reference is made to Orkla's stock exchange notice dated February
5th, 2007, in connection with Orkla's acquisition of app. 12.48% of
the shares in Renewable Energy Corporation ASA (REC) from Good
Energies Investments B.V. (GEI). At the same time, GEI sold app.
17.9% of the outstanding shares in REC to Q-Cells AG. In connection
with these transactions, Orkla issued put options in favour of
Q-Cells, and acquired certain rights with respect to Q-Cells' shares
in REC, as described in the stock exchange notice.
Â
Orkla and Q-Cells have today entered into an agreement to terminate
both the put options and Orkla's rights with respect to Q-Cells'
shares in REC, with immediate effect. All parties' rights and
obligations under the option agreement thereby cease to apply.
The net value of the rights and obligations at 31 December 2007 was
estimated at
 - NOK 67 million on Orkla's balance sheet.
There is no capital expenditure incumbent upon any of the parties in
connection with the termination of the agreements.
Â
Orkla ASA,
Oslo 14 February 2008
Â
Contact Orkla Investor Relations:
Rune Helland, SVP Investor Relations, Tel: +472254 4411
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.